Stemi Cardioprotection
Stemi Cardioprotection - Related Videos
05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
0 Views •
Cited by 5 •
2019
Herein, we present a protocol for postconditioning with lactate-enriched blood, which is a novel approach for cardioprotection. This protocol comprises intermittent reperfusion and timely coronary injections of lactated Ringer's solution. This can be applied to ST-segment elevation myocardial infarction patients who undergo primary percutaneous coronary intervention.
08:30
Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
0 Views •
Cited by 21 •
2011
A murine model for myocardial ischemia and ischemic preconditioning is an important tool study cardioprotective mechanisms in vivo. Here, we report an easy applicable in situ model for cardiac IP using a hanging-weight system for coronary artery occlusion.
08:28
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
0 Views •
Cited by 3 •
2011
Techniques for measurement of electrical activity of the heart by electrocardiogram (ECG), and analysis of cardiac risk factors and susceptibility to arrhythmias following status epilepticus (SE) in the rat are described.
13:51
Cross-Modal Multivariate Pattern Analysis
0 Views •
Cited by 5 •
2011
Classical multivariate pattern analysis predicts sensory stimuli a subject perceives from neural activity in the corresponding cortices (e.g. visual stimuli from activity in visual cortex). Here, we apply pattern analysis cross-modally and show that sound- and touch-implying visual stimuli can be predicted from activity in auditory and somatosensory cortices, respectively.
18:11
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
0 Views •
Cited by 13 •
2012
Continuous 12-lead electrocardiographic (ECG) monitoring can identify transient myocardial ischemia, even when asymptomatic, among patients with suspected acute coronary syndrome (ACS). In this article we describe our method for initiating patient monitoring using a Holter device, downloading the ECG data for off-line analysis, and how to utilize the ECG software to identify transient ischemia.
FAQs
Reperfusion can intensify oxidative stress, inflammation, calcium overload, and mitochondrial dysfunction in previously ischemic myocardium. These processes may impair cellular recovery even after the blocked coronary artery has been reopened. Cardioprotective strategies therefore aim to control injury during the transition from ischemia to restored flow, rather than treating reperfusion as an entirely risk-free endpoint.
The main targets include excessive reactive oxidative stress, inflammatory activity, abnormal calcium accumulation, mitochondrial dysfunction, and microvascular obstruction. Each can interfere with myocardial salvage after blood flow returns, although the mechanisms are interconnected rather than isolated. Addressing these pathways is intended to preserve viable myocardium, limit infarct size, and support subsequent recovery of cardiac function.
Pharmacological approaches use drugs or other biochemical interventions, whereas mechanical methods apply a physical intervention to influence injury during reperfusion. Ischemic conditioning uses controlled episodes of ischemia and reperfusion as the protective stimulus. These approaches differ in how they engage cardioprotective pathways, but all are studied for their ability to reduce reperfusion-related myocardial damage.
Cardioprotection is studied alongside timely reperfusion and primary percutaneous coronary intervention, not as a substitute for restoring coronary blood flow. The clinical challenge is to preserve the benefits of rapid vessel reopening while limiting injury that may occur during reperfusion. This combined focus links procedural success with myocardial salvage and later cardiac function.
Evaluation focuses on whether an intervention limits myocardial injury and preserves cardiac performance after acute infarction. Relevant outcomes include infarct size, myocardial viability, microvascular obstruction, and measures of cardiac function. Longer-term assessment also considers heart failure, adverse remodeling, and other complications, helping determine whether an observed protective effect has meaningful clinical importance.
In medicine, this research supports development of treatments that can improve outcomes after acute myocardial infarction. Investigators compare pharmacological, mechanical, and ischemic-conditioning strategies in the setting of reperfusion and primary percutaneous coronary intervention. The broader goal is to identify approaches that preserve myocardium early and reduce later heart failure, adverse remodeling, and long-term cardiac complications.